Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario L de Lemos

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|June 11, 2002
Storm over screening for prostate specific antigen. Number needed to test needs to be knownMario L de Lemos
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 29, 2003
The return of "negative" trials?Mario L de Lemos
The New England Journal of Medicine|May 31, 2003
Inappropriate advertising of dietary supplementsMario L de Lemos
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 2, 2005
NNT for studies with long-term follow-upMario L de Lemos
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 27, 2004
Seeking clarification of osteoporosis guidelinesMario L de Lemos
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 25, 2014
Clinical efficacy of generic imatinibMario L de Lemos, Victoria Kyritsis
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 22, 2013
Hazards in determining whether a drug is hazardousNadine Badry, Joan Fabbro, Mario L de Lemos
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 10, 2013
Trastuzumab therapy in breast cancer: To reload or not to reload?Mario L de Lemos, Karen Mason, Nadine Badry, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 24, 2018
Evaluation of the role of pharmacy technicians in reviewing the eligibility for Oncotype DX genomic test and the impact of the test on treatment plans in breast cancer patientsVian Cheng, Adeline Markarian, Mario L de Lemos, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2022
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditionsAndrew Walker, Alexandre Chan, Constanza Cortés Labra, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|June 11, 2002
Storm over screening for prostate specific antigen. Number needed to test needs to be knownMario L de Lemos
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 29, 2003
The return of "negative" trials?Mario L de Lemos
The New England Journal of Medicine|May 31, 2003
Inappropriate advertising of dietary supplementsMario L de Lemos
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 2, 2005
NNT for studies with long-term follow-upMario L de Lemos
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 27, 2004
Seeking clarification of osteoporosis guidelinesMario L de Lemos
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 25, 2014
Clinical efficacy of generic imatinibMario L de Lemos, Victoria Kyritsis
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 22, 2013
Hazards in determining whether a drug is hazardousNadine Badry, Joan Fabbro, Mario L de Lemos
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 10, 2013
Trastuzumab therapy in breast cancer: To reload or not to reload?Mario L de Lemos, Karen Mason, Nadine Badry, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 24, 2018
Evaluation of the role of pharmacy technicians in reviewing the eligibility for Oncotype DX genomic test and the impact of the test on treatment plans in breast cancer patientsVian Cheng, Adeline Markarian, Mario L de Lemos, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2022
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditionsAndrew Walker, Alexandre Chan, Constanza Cortés Labra, et al.
Pageof 1